Related Resources

Press Release | AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma
Press Release | ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform
Contact Us

Are you looking to accelerate your program or just want to learn more about our services?

Connect with our team and we will get back to you quickly.

View Capabilities

Connect with our team and we will get back to you quickly.

View Capabilities
JSR_Logo_footer-01

Copyright © 2019 KBI Biopharma. All Rights Reserved. | Privacy Policy